These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Arabinoxylan rice bran (MGN-3) enhances the effects of interventional therapies for the treatment of hepatocellular carcinoma: a three-year randomized clinical trial. Bang MH; Van Riep T; Thinh NT; Song le H; Dung TT; Van Truong L; Van Don L; Ky TD; Pan D; Shaheen M; Ghoneum M Anticancer Res; 2010 Dec; 30(12):5145-51. PubMed ID: 21187503 [TBL] [Abstract][Full Text] [Related]
8. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma]. Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial. Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260 [TBL] [Abstract][Full Text] [Related]
10. [Percutaneous tumor ablation therapy for the advanced stage of HCC]. Teratani T; Shiina S; Obi S; Hamamura K; Koike Y; Akamatsu M; Fujishima T; Tateishi R; Imai Y; Shiratori Y; Omata M Gan To Kagaku Ryoho; 2000 Sep; 27(10):1496-500. PubMed ID: 11015992 [TBL] [Abstract][Full Text] [Related]
11. Recurrence incidence of small HCC in cirrhosis patients by ablation versus injection. Wakui N; Iida K; Ikehara T; Takayama R; Shiozawa K; Takahashi M; Nagai H; Watanabe M; Ishii K; Igarashi Y; Sumino Y Hepatogastroenterology; 2010; 57(98):195-201. PubMed ID: 20583411 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience. Montella L; Addeo R; Caraglia M; Faiola V; Guarrasi R; Vincenzi B; Palmeri A; Capasso E; Nocera V; Tarantino L; Ariete M; Martorelli A; Del Prete S Oncol Rep; 2008 Aug; 20(2):385-90. PubMed ID: 18636202 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514 [TBL] [Abstract][Full Text] [Related]
14. Radiofrequency thermal ablation versus percutaneous ethanol injection for small hepatocellular carcinoma. Giorgio A; Ferraioli G Radiology; 2004 Mar; 230(3):886; author reply 886-7. PubMed ID: 14990849 [No Abstract] [Full Text] [Related]
15. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy. Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297 [TBL] [Abstract][Full Text] [Related]